4-boronophenylalanine has been researched along with Lung Neoplasms in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Altieri, S; Aromando, RF; Bortolussi, S; Colombo, LL; Farías, RO; Garabalino, MA; González, SJ; Itoiz, ME; Monti Hughes, A; Nigg, DW; Pozzi, EC; Schwint, AE; Trivillin, VA | 1 |
Altieri, S; Bakeine, GJ; Bertolotti, A; Bortolussi, S; Bruschi, P; Clerici, A; Di Salvo, M; Ferrari, C; Marchetti, A; Nano, R; Stella, S; Zonta, C | 1 |
Coderre, JA; Glass, JD; Greenberg, D; Micca, P; Packer, S | 1 |
3 other study(ies) available for 4-boronophenylalanine and Lung Neoplasms
Article | Year |
---|---|
Biodistribution of the boron carriers boronophenylalanine (BPA) and/or decahydrodecaborate (GB-10) for Boron Neutron Capture Therapy (BNCT) in an experimental model of lung metastases.
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Cell Line, Tumor; Drug Combinations; Lung Neoplasms; Metabolic Clearance Rate; Organ Specificity; Phenylalanine; Radiotherapy Dosage; Rats; Tissue Distribution | 2014 |
Feasibility study on the utilization of boron neutron capture therapy (BNCT) in a rat model of diffuse lung metastases.
Topics: Animals; Boron Compounds; Boron Neutron Capture Therapy; Cell Line, Tumor; Cell Survival; Colonic Neoplasms; Disease Models, Animal; In Vitro Techniques; Lung Neoplasms; Phenylalanine; Radiation Tolerance; Radiation-Sensitizing Agents; Rats | 2009 |
Experimental boron neutron capture therapy for melanoma: systemic delivery of boron to melanotic and amelanotic melanoma.
Topics: Animals; Boron; Boron Compounds; Eye Neoplasms; Isotopes; Lung Neoplasms; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Nude; Neutrons; Phenylalanine; Rabbits; Radiation-Sensitizing Agents; Transplantation, Heterologous | 1990 |